Q1 2025 Ashland Inc Earnings Call Transcript
Key Points
- Ashland Inc (ASH) reported a strong performance in Personal Care, achieving its fourth consecutive quarter of over 25% year-over-year EBITDA growth, driven by strong demand in Skin Care and Hair Care.
- The company successfully executed strategic portfolio optimization initiatives, including the divestiture of the Nutraceutical business, which improved long-term profitability.
- Ashland Inc (ASH) maintained stable pricing in Specialty Additives, with a significant narrowing of year-over-year decline to just 1%, reflecting disciplined pricing strategy.
- The company is on track with its $90 million cost-saving target, having already achieved $12 million in annual run rate savings from restructuring efforts.
- Ashland Inc (ASH) reaffirmed its full-year sales and adjusted EBITDA outlook, demonstrating confidence in achieving its financial targets despite market uncertainties.
- Ashland Inc (ASH) experienced a 14% year-over-year decline in Q1 sales, primarily due to portfolio optimization actions, including the Nutraceutical divestiture.
- The Life Sciences segment faced challenges with a 33% decline in sales, impacted by softer pharma markets and customer inventory control measures, particularly in Europe.
- Adjusted EBITDA decreased by 13% year-over-year, driven by loss of gross profit from divestitures and stranded costs from portfolio optimization actions.
- The company faced increased competition and pricing pressure in China, impacting volumes and pricing in local and export markets.
- Currency fluctuations, particularly the depreciation of the euro, yuan, and real, pose a potential headwind for Ashland Inc (ASH)'s EBITDA for the remainder of the fiscal year.
Good day, and thank you for standing by. Welcome to the Ashland Inc. first quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, William Whitaker. Please go ahead.
Hello, everyone, and welcome to Ashland's first quarter fiscal year 2025 earnings conference call and webcast. My name is William Whitaker, Ashland Investor Relations. Joining me on the call today are Guillermo Novo, Ashland Chair and CEO; Kevin Willis, Ashland's CFO; and our business unit leaders, Alessandra Faccin, Jim Minicucci and Dago Caceres.
Ashland released results for the quarter ended December 31, 2024, at approximately 5:00 PM Eastern time yesterday, January 28. The news release issued last night was furnished to the SEC in a Form 8-K. During today's call, we will reference slides that are currently being webcast on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

